112 related articles for article (PubMed ID: 36923576)
1. Pneumococcal Vaccination Practices in Patients With Multiple Sclerosis Receiving Anti-CD20 Monoclonal Antibodies After Pharmacy and Nursing Collaboration.
Reindel K; Rightmier E; Dean JS; Qualls BW; Wawrzyniak J
Int J MS Care; 2023; 25(2):71-74. PubMed ID: 36923576
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital.
Smith JG; Metzger NL
J Manag Care Pharm; 2011 Nov; 17(9):701-8. PubMed ID: 22050395
[TBL] [Abstract][Full Text] [Related]
3. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
Nuorti JP; Whitney CG;
MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
[TBL] [Abstract][Full Text] [Related]
4. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older.
Jackson LA; Gurtman A; van Cleeff M; Frenck RW; Treanor J; Jansen KU; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
Vaccine; 2013 Aug; 31(35):3594-602. PubMed ID: 23688525
[TBL] [Abstract][Full Text] [Related]
5. Leveraging Interdisciplinary Teams for Pre-Visit Planning to Improve Pneumococcal Immunization Rates Among Internal Medicine Subspecialty Practices.
Shafer R; Kearns C; Carney M; Sagar A
J Prim Care Community Health; 2021; 12():21501319211060986. PubMed ID: 34866486
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years.
Black CL; Williams WW; Warnock R; Pilishvili T; Kim D; Kelman JA
MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(27):728-733. PubMed ID: 28704347
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccination in the emergency department: an assessment of need.
Rudis MI; Stone SC; Goad JA; Lee VW; Chitchyan A; Newton KI
Ann Emerg Med; 2004 Oct; 44(4):386-92. PubMed ID: 15459621
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist impact on pneumococcal polysaccharide vaccination rates in patients with diabetes in a national grocery chain pharmacy.
Page A; Harrison A; Nadpara P; Goode JR
J Am Pharm Assoc (2003); 2020; 60(3S):S51-S55.e1. PubMed ID: 32192948
[TBL] [Abstract][Full Text] [Related]
9. Combined 13-valent pneumococcal conjugate and 23-valent pneumococcal polysaccharide vaccine regimens for adults with systemic lupus erythematosus: Does the sequence of pneumococcal vaccination affect immunogenicity responses? A single-center cohort study in Brazil.
Rezende RPV; Oliveira-Santos M; Andrade LEC; Klumb EM
Lupus; 2023 Apr; 32(5):694-703. PubMed ID: 36705619
[TBL] [Abstract][Full Text] [Related]
10. Improving Pneumococcal Vaccination in Pediatric Rheumatology Patients.
Harris JG; Maletta KI; Ren B; Olson JC
Pediatrics; 2015 Sep; 136(3):e681-6. PubMed ID: 26304825
[TBL] [Abstract][Full Text] [Related]
11. A virtual clinic improves pneumococcal vaccination coverage among patients living with HIV at a Veterans Affairs Medical Center.
Burns CM; Banks RE; Wilson BM; Carter RR; Jump RLP; Perez F
AIDS Care; 2018 Feb; 30(2):146-149. PubMed ID: 29052434
[TBL] [Abstract][Full Text] [Related]
12. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.
Cordonnier C; Labopin M; Chesnel V; Ribaud P; De La Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Einsele H; Niederwieser D; Apperley J; Ljungman P;
Clin Infect Dis; 2009 May; 48(10):1392-401. PubMed ID: 19368505
[TBL] [Abstract][Full Text] [Related]
13. Response to pneumococcal conjugate and polysaccharide vaccination in children with rheumatic disease.
Jensen L; Christensen AE; Nielsen S; Pedersen FK; Rosthøj S; Jørgensen CS; Poulsen A
Scand J Immunol; 2022 Feb; 95(2):e13118. PubMed ID: 34768311
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S
Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293
[TBL] [Abstract][Full Text] [Related]
15. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.
Matanock A; Lee G; Gierke R; Kobayashi M; Leidner A; Pilishvili T
MMWR Morb Mortal Wkly Rep; 2019 Nov; 68(46):1069-1075. PubMed ID: 31751323
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.
Kobayashi M; Pilishvili T; Farrar JL; Leidner AJ; Gierke R; Prasad N; Moro P; Campos-Outcalt D; Morgan RL; Long SS; Poehling KA; Cohen AL
MMWR Recomm Rep; 2023 Sep; 72(3):1-39. PubMed ID: 37669242
[No Abstract] [Full Text] [Related]
17. A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapies.
Stoll S; Desai S; Levit E
Mult Scler Relat Disord; 2023 Mar; 71():104574. PubMed ID: 36827874
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Jackson LA; Gurtman A; Rice K; Pauksens K; Greenberg RN; Jones TR; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
Vaccine; 2013 Aug; 31(35):3585-93. PubMed ID: 23688527
[TBL] [Abstract][Full Text] [Related]
19. Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults.
Schmoele-Thoma B; van Cleeff M; Greenberg RN; Gurtman A; Jones TR; Sundaraiyer V; Gruber WC; Scott DA
Hum Vaccin Immunother; 2019; 15(3):575-583. PubMed ID: 30648932
[TBL] [Abstract][Full Text] [Related]
20. Costs of adult vaccination in medical settings and pharmacies: an observational study.
Singhal PK; Zhang D
J Manag Care Spec Pharm; 2014 Sep; 20(9):930-6. PubMed ID: 25166292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
